Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
Sofie Van Ackerbroeck, Lynn Rutsaert, Ella Roelant, Kathleen Dillen, Joost Wauters, Niels Van Regenmortel
Abstract
status: Published
Topics & Concepts
MedicineAspergillosisAmphotericin BCoronavirus disease 2019 (COVID-19)Pulmonary aspergillosisAspergillusIntensive care medicineAspergillus fumigatusMicrobiologyImmunologyInternal medicineAntifungalDermatologyInfectious disease (medical specialty)BiologyDiseaseAntifungal resistance and susceptibilityInhalation and Respiratory Drug DeliveryCystic Fibrosis Research Advances